Search
News
Indices
Experts agree: US midterms and AI jitters might damage confidence in the US Dollar
The US Dollar (USD) has retraced most of its previous losses on Monday, but remains on the defensive with investors wary of holding large US Dollar longs ahead of the US midterm elections, while growing concerns about an AI bubble pose an additional threat.
Fxstreet
Mon, Nov 2
Economic Indicator
Equities: AI themes support selective overweight – HSBC
HSBC’s Willem Sels and Lucia Ku highlight that global equities remain supported by AI-driven earnings and strategic government priorities. They keep an Overweight stance on global and US stocks, favouring Technology and broader AI ecosystem plays, while staying Neutral on Europe ex-UK and Emerging Markets. Japan and Asia ex-Japan are preferred for AI exposure, with selectivity across sectors and regions stressed.Fxstreet
Mon, Nov 2
Stocks
YYForce Highlights US$21.9 Million in Reported Net Assets and Outlines Commercial Robotics and AI Platform Priorities
YYForce presents its reported book equity alongside its market capitalization to give investors additional context for its growth plans SINGAPORE, Nov. 2, 2026 /PRNewswire/ -- YYForce Inc. (Nasdaq: YFOR)("YYForce" or the "Company"), a technology-enabled provider of workforce solutio...PR Newswire
Mon, Nov 2
Earnings
Marriott Q3 2026 Earnings: RevPAR Growth Drives Fee Revenue Higher
Marriott International (MAR) reported Q3 2026 revenue of $7.005 billion, up 8%, as diluted EPS increased 14% to $3.04 and worldwide RevPAR rose 6.5%. Higher room rates, occupancy, net unit growth, and co-branded credit card fees supported faster fee growth and improved adjusted operating margin. Marriott raised its full-year RevPAR outlook, while investors still need to monitor weaker Middle East and Greater China trends, a lower contribution from owned and leased hotels, and rising debt-related interest expense over the coming quarters.
TradingKey
Mon, Nov 2
Earnings
Tempus AI Q3 2026 Earnings: Revenue Rises 23% as Adjusted EBITDA Expands
Tempus AI (NASDAQ: TEM) reported Q3 2026 revenue of $411.5 million, up 23% year over year, while GAAP diluted loss per share narrowed to $0.08 from $0.46. Adjusted EBITDA rose to $25.6 million from $1.5 million, supported by 33% growth in Data and Applications and 20% growth in Diagnostics. Gross margin expanded to about 64.8%, although Tempus still posted a $56.9 million operating loss. The company raised full-year revenue guidance to $1.60-$1.605 billion and maintained adjusted EBITDA guidance of approximately $65 million.TradingKey
Mon, Nov 2
Stocks
Infineum Expands India Footprint with New Mumbai Office as Demand for High-Performance Lubricants Grows
MUMBAI, India, Nov. 2, 2026 /PRNewswire/ -- Infineum, a global leader in specialty additives, today officially opened the new premises for its India office in Andheri East, Mumbai, reinforcing its long-term commitment to one of the world's fastest-growing mobility and energy markets. The op...PR Newswire
Mon, Nov 2
Stocks
TD Brings its Global Asset Management Businesses Under One Name
TD Global Investment Solutions will become TD Asset Management, simplifying how clients engage with the firm globally TORONTO, Nov. 2, 2026 /PRNewswire/ -- TD Global Investment Solutions will now operate under the TD Asset Management (TDAM) name, creating one consistent global brand across the firm...PR Newswire
Mon, Nov 2
Stocks
OncoC4 Appoints Dr. Dan Janiak as Chief Business Officer
ROCKVILLE, Md., Nov. 2, 2026 /PRNewswire/ --OncoC4, Inc., a late clinical-stage biopharmaceutical company developing novel medicines for cancer and immunological diseases, today announced the appointment of Dr. Dan Janiak as Chief Business Officer. Dan brings more than 15 years of experience buil...PR Newswire
Mon, Nov 2
Stocks
Kazia Therapeutics Announces Two Abstracts on Paxalisib Tumor and Immune Reprogramming Research Accepted for Poster Presentation at 2026 San Antonio Breast Cancer Symposium
Presentations to Explore Paxalisib's Differentiated Tumor and Immune Reprogramming Activity SYDNEY, Nov. 2, 2026 /PRNewswire/ -- Kazia Therapeutics Limited(NASDAQ: KZIA) ("Kazia" or the "Company"), an oncology-focused biotechnology company developing therapies that selectively r...PR Newswire
Mon, Nov 2
Cryptocurrencies
Bitcoin Price Forecast: BTC slips below $78,000 amid ETF outflows
Bitcoin (BTC) slips below $78,000 at the time of writing on Monday after posting its fourth straight weekly loss. Institutional demand shows signs of weakening, with spot Exchange Traded Funds (ETFs) recording outflows of over $202 million last week.
Fxstreet
Mon, Nov 2
Earnings
Entergy Q3 2026 Earnings: Utility Growth Lifts EPS to $1.98
Entergy (NYSE: ETR) reported Q3 2026 earnings of $940 million, up from $694 million, while GAAP and adjusted EPS increased to $1.98 from $1.53. Utility earnings rose to $1.079 billion as higher retail sales, weather, regulatory actions, and returns on construction work in progress outweighed higher interest, O&M, and depreciation costs. Quarterly operating cash flow reached $2.235 billion, and Entergy narrowed 2026 adjusted EPS guidance to $4.35-$4.45. Investors should monitor financing costs, weather-normalized demand, regulatory execution, and the balance between higher debt and improved liquidity.
TradingKey
Mon, Nov 2
Earnings
IDEXX Q3 2026 Earnings: Recurring Diagnostics Growth Lifts Margins
IDEXX Laboratories reported Q3 2026 revenue of $1.214 billion, up 10% year over year on both a reported and organic basis, while diluted EPS increased 18% to $4.01. CAG Diagnostics recurring revenue grew 11%, led by VetLab consumables and reference laboratory testing, helping gross margin expand 110 basis points to 62.9%. IDEXX raised its full-year revenue and EPS outlooks but lowered its operating-margin range to 32.1%-32.3%. CoVet integration and sustained diagnostic volume growth remain key operating considerations.
TradingKey
Mon, Nov 2
Stocks
BingX Wraps Up TOKEN2049 Singapore 2026 as Title Sponsor, Showcasing "Building the Future of Trading" Vision
PANAMA CITY, Nov. 2, 2026 /PRNewswire/ --BingX, the world's leading multi-asset trading platform, has concluded its participation as Title Sponsor of TOKEN2049 Singapore 2026, held October 7–8. Under the theme "Building the Future of Trading," BingX showcased its vision for a more connec...PR Newswire
Mon, Nov 2
Indices
US Dollar: Softer tone into elections – MUFG
MUFG’s Lee Hardman highlights US mid-term election risks, with a potential Republican loss of Congress seen as dampening Dollar strength. A less hawkish Fed, lower US Treasury yields and pressure on US AI-related equities add downside risks for the Dollar.Fxstreet
Mon, Nov 2
Featured Tools
Top News
DomoAI Launches InkoAI Agent - One Sentence to Ready-to-Post Video
Gold Price Forecast: Gold Tumbles Below $3,900 as Trump Says No Need for Iran Deal; Can October PPI Spur a Rebound?
US October PPI Preview: Fed Rate Hike Expectations Rise, PPI May Be Key Variable; How Will US Stocks, Dollar, and Gold Move?
【US Pre-Market】Nvidia Rebounds Over 2%; Microsoft Falls Over 2% Amid Massive Global Outage; October PPI Due
Nasdaq Extends Drop by 0.91% as Tech Stocks Lead Declines, AMD Falls Nearly 9%, Nvidia Drops 2%
